167 related articles for article (PubMed ID: 38069229)
1.
Zelaya H; Arellano-Arriagada L; Fukuyama K; Matsumoto K; Marranzino G; Namai F; Salva S; Alvarez S; Agüero G; Kitazawa H; Villena J
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069229
[No Abstract] [Full Text] [Related]
2. Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C).
Villena J; Chiba E; Tomosada Y; Salva S; Marranzino G; Kitazawa H; Alvarez S
BMC Immunol; 2012 Sep; 13():53. PubMed ID: 22989047
[TBL] [Abstract][Full Text] [Related]
3. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage.
Zelaya H; Tada A; Vizoso-Pinto MG; Salva S; Kanmani P; Agüero G; Alvarez S; Kitazawa H; Villena J
Inflamm Res; 2015 Aug; 64(8):589-602. PubMed ID: 26072063
[TBL] [Abstract][Full Text] [Related]
4. Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered
Garcia-Castillo V; Tomokiyo M; Raya Tonetti F; Islam MA; Takahashi H; Kitazawa H; Villena J
Front Immunol; 2020; 11():568636. PubMed ID: 33133080
[TBL] [Abstract][Full Text] [Related]
5. The Mucus Binding Factor Is Not Necessary for
Tomotsune K; Raya Tonetti F; Mizuno H; Elean M; Fukuyama K; Zhou B; Ikeda-Ohtsubo W; Nishiyama K; Yamamura A; Karasawa H; Ohnuma S; Horii A; Saito T; Kitazawa H; Villena J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430834
[TBL] [Abstract][Full Text] [Related]
6. Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection.
Chiba E; Tomosada Y; Vizoso-Pinto MG; Salva S; Takahashi T; Tsukida K; Kitazawa H; Alvarez S; Villena J
Int Immunopharmacol; 2013 Oct; 17(2):373-82. PubMed ID: 23838113
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the inflammation-coagulation interaction during pneumococcal pneumonia by immunobiotic Lactobacillus rhamnosus CRL1505: role of Toll-like receptor 2.
Zelaya H; Villena J; Lopez AG; Alvarez S; Agüero G
Microbiol Immunol; 2014 Jul; 58(7):416-26. PubMed ID: 24888715
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus rhamnosus CRL1505 beneficially modulates the immuno-coagulative response after pneumococcal infection in immunocompromised malnourished mice.
Zelaya H; Laiño J; Villena J; Alvarez S; Agüero G
Can J Microbiol; 2013 Oct; 59(10):684-93. PubMed ID: 24102222
[TBL] [Abstract][Full Text] [Related]
9. Immunobiotic lactobacilli reduce viral-associated pulmonary damage through the modulation of inflammation-coagulation interactions.
Zelaya H; Tsukida K; Chiba E; Marranzino G; Alvarez S; Kitazawa H; Agüero G; Villena J
Int Immunopharmacol; 2014 Mar; 19(1):161-73. PubMed ID: 24394565
[TBL] [Abstract][Full Text] [Related]
10. Immunobiotic Lactobacillus strains reduce small intestinal injury induced by intraepithelial lymphocytes after Toll-like receptor 3 activation.
Tada A; Zelaya H; Clua P; Salva S; Alvarez S; Kitazawa H; Villena J
Inflamm Res; 2016 Oct; 65(10):771-83. PubMed ID: 27279272
[TBL] [Abstract][Full Text] [Related]
11. Non-viable immunobiotic Lactobacillus rhamnosus CRL1505 and its peptidoglycan improve systemic and respiratory innate immune response during recovery of immunocompromised-malnourished mice.
Kolling Y; Salva S; Villena J; Marranzino G; Alvarez S
Int Immunopharmacol; 2015 Apr; 25(2):474-84. PubMed ID: 25744605
[TBL] [Abstract][Full Text] [Related]
12. Oral Administration of
Dentice Maidana S; Imamura Y; Elean M; Albarracín L; Nishiyama K; Suda Y; Kurata S; Jure MÁ; Kitazawa H; Villena J
Microorganisms; 2023 Apr; 11(5):. PubMed ID: 37317122
[TBL] [Abstract][Full Text] [Related]
13. The Role of Alveolar Macrophages in the Improved Protection against Respiratory Syncytial Virus and Pneumococcal Superinfection Induced by the Peptidoglycan of
Clua P; Tomokiyo M; Raya Tonetti F; Islam MA; García Castillo V; Marcial G; Salva S; Alvarez S; Takahashi H; Kurata S; Kitazawa H; Villena J
Cells; 2020 Jul; 9(7):. PubMed ID: 32660087
[TBL] [Abstract][Full Text] [Related]
14. The Mucus-Binding Factor Mediates
Zhou B; Elean M; Arce L; Fukuyama K; Tomotsune K; Dentice Maidana S; Saha S; Namai F; Nishiyama K; Vizoso-Pinto MG; Villena J; Kitazawa H
Microorganisms; 2024 Jun; 12(6):. PubMed ID: 38930591
[No Abstract] [Full Text] [Related]
15. Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection.
Tomosada Y; Chiba E; Zelaya H; Takahashi T; Tsukida K; Kitazawa H; Alvarez S; Villena J
BMC Immunol; 2013 Aug; 14():40. PubMed ID: 23947615
[TBL] [Abstract][Full Text] [Related]
16. Efficient Selection of New Immunobiotic Strains With Antiviral Effects in Local and Distal Mucosal Sites by Using Porcine Intestinal Epitheliocytes.
Albarracin L; Garcia-Castillo V; Masumizu Y; Indo Y; Islam MA; Suda Y; Garcia-Cancino A; Aso H; Takahashi H; Kitazawa H; Villena J
Front Immunol; 2020; 11():543. PubMed ID: 32322251
[TBL] [Abstract][Full Text] [Related]
17. Nasal priming with immunobiotic lactobacilli improves the adaptive immune response against influenza virus.
Tonetti FR; Islam MA; Vizoso-Pinto MG; Takahashi H; Kitazawa H; Villena J
Int Immunopharmacol; 2020 Jan; 78():106115. PubMed ID: 31841753
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus rhamnosus CRL1505 nasal administration improves recovery of T-cell mediated immunity against pneumococcal infection in malnourished mice.
Barbieri N; Herrera M; Salva S; Villena J; Alvarez S
Benef Microbes; 2017 May; 8(3):393-405. PubMed ID: 28504568
[TBL] [Abstract][Full Text] [Related]
19. The Ability of Postimmunobiotics from
Raya Tonetti F; Clua P; Fukuyama K; Marcial G; Sacur J; Marranzino G; Tomokiyo M; Vizoso-Pinto G; Garcia-Cancino A; Kurata S; Kitazawa H; Villena J
Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36363777
[TBL] [Abstract][Full Text] [Related]
20. Immunobiotic Lactobacillus rhamnosus strains differentially modulate antiviral immune response in porcine intestinal epithelial and antigen presenting cells.
Villena J; Chiba E; Vizoso-Pinto MG; Tomosada Y; Takahashi T; Ishizuka T; Aso H; Salva S; Alvarez S; Kitazawa H
BMC Microbiol; 2014 May; 14():126. PubMed ID: 24886142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
